Cargando…
Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
This was a cross-sectional study designed to assess the validity of the Finnish Diabetes Risk Score for detecting undiagnosed type 2 diabetes among general medical outpatients in Botswana. Participants aged ≥20 years without previously diagnosed diabetes were screened by (1) an 8-item Finnish diabet...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055990/ https://www.ncbi.nlm.nih.gov/pubmed/27738638 http://dx.doi.org/10.1155/2016/4968350 |
_version_ | 1782458834278678528 |
---|---|
author | Omech, Bernard Mwita, Julius Chacha Tshikuka, Jose-Gaby Tsima, Billy Nkomazna, Oathokwa Amone-P'Olak, Kennedy |
author_facet | Omech, Bernard Mwita, Julius Chacha Tshikuka, Jose-Gaby Tsima, Billy Nkomazna, Oathokwa Amone-P'Olak, Kennedy |
author_sort | Omech, Bernard |
collection | PubMed |
description | This was a cross-sectional study designed to assess the validity of the Finnish Diabetes Risk Score for detecting undiagnosed type 2 diabetes among general medical outpatients in Botswana. Participants aged ≥20 years without previously diagnosed diabetes were screened by (1) an 8-item Finnish diabetes risk assessment questionnaire and (2) Haemoglobin A1c test. Data from 291 participants were analyzed (74.2% were females). The mean age of the participants was 50.1 (SD = ±11) years, and the prevalence of undiagnosed diabetes was 42 (14.4%) with no significant differences between the gender (20% versus 12.5%, P = 0.26). The area under curve for detecting undiagnosed diabetes was 0.63 (95% CI 0.55–0.72) for the total population, 0.65 (95% CI: 0.56–0.75) for women, and 0.67 (95% CI: 0.52–0.83) for men. The optimal cut-off point for detecting undiagnosed diabetes was 17 (sensitivity = 48% and specificity = 73%) for the total population, 17 (sensitivity = 56% and specificity = 66%) for females, and 13 (sensitivity = 53% and specificity = 77%) for males. The positive predictive value and negative predictive value were 20% and 89.5%, respectively. The findings indicate that the Finnish questionnaire was only modestly effective in predicting undiagnosed diabetes among outpatients in Botswana. |
format | Online Article Text |
id | pubmed-5055990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-50559902016-10-13 Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana Omech, Bernard Mwita, Julius Chacha Tshikuka, Jose-Gaby Tsima, Billy Nkomazna, Oathokwa Amone-P'Olak, Kennedy J Diabetes Res Research Article This was a cross-sectional study designed to assess the validity of the Finnish Diabetes Risk Score for detecting undiagnosed type 2 diabetes among general medical outpatients in Botswana. Participants aged ≥20 years without previously diagnosed diabetes were screened by (1) an 8-item Finnish diabetes risk assessment questionnaire and (2) Haemoglobin A1c test. Data from 291 participants were analyzed (74.2% were females). The mean age of the participants was 50.1 (SD = ±11) years, and the prevalence of undiagnosed diabetes was 42 (14.4%) with no significant differences between the gender (20% versus 12.5%, P = 0.26). The area under curve for detecting undiagnosed diabetes was 0.63 (95% CI 0.55–0.72) for the total population, 0.65 (95% CI: 0.56–0.75) for women, and 0.67 (95% CI: 0.52–0.83) for men. The optimal cut-off point for detecting undiagnosed diabetes was 17 (sensitivity = 48% and specificity = 73%) for the total population, 17 (sensitivity = 56% and specificity = 66%) for females, and 13 (sensitivity = 53% and specificity = 77%) for males. The positive predictive value and negative predictive value were 20% and 89.5%, respectively. The findings indicate that the Finnish questionnaire was only modestly effective in predicting undiagnosed diabetes among outpatients in Botswana. Hindawi Publishing Corporation 2016 2016-09-22 /pmc/articles/PMC5055990/ /pubmed/27738638 http://dx.doi.org/10.1155/2016/4968350 Text en Copyright © 2016 Bernard Omech et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Omech, Bernard Mwita, Julius Chacha Tshikuka, Jose-Gaby Tsima, Billy Nkomazna, Oathokwa Amone-P'Olak, Kennedy Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana |
title | Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana |
title_full | Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana |
title_fullStr | Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana |
title_full_unstemmed | Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana |
title_short | Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana |
title_sort | validity of the finnish diabetes risk score for detecting undiagnosed type 2 diabetes among general medical outpatients in botswana |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055990/ https://www.ncbi.nlm.nih.gov/pubmed/27738638 http://dx.doi.org/10.1155/2016/4968350 |
work_keys_str_mv | AT omechbernard validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana AT mwitajuliuschacha validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana AT tshikukajosegaby validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana AT tsimabilly validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana AT nkomaznaoathokwa validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana AT amonepolakkennedy validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana |